Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective histone deacetylase inhibitors for the treatment of human disease

Selective histone deacetylase inhibitors for the treatment of human disease

US Patent 11407723 · Granted Aug 9, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for cancer therapies that include delivery of halogenat2025
Methods and compositions for cancer therapies that include delivery of halogenat2025
Methods and compositions for cancer therapies that include delivery of halogenat2025
Selective histone deacetylase inhibitors for the treatment of human disease2024
Selective histone deacetylase inhibitors for the treatment of human disease2024
Selective histone deacetylase inhibitors for the treatment of human disease2024
Methods and compositions for cancer therapies that include delivery of halogenat2023
Methods and compositions for cancer therapies that include delivery of halogenat2023
Methods and compositions for cancer therapies that include delivery of halogenat2023
Selective histone deacetylase inhibitors for the treatment of human disease2023
Selective histone deacetylase inhibitors for the treatment of human disease2023
Selective histone deacetylase inhibitors for the treatment of human disease2023